Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Caffeine for Hypoxic Ischemic Encephalopathy (CHIME Trial)

NCT06855108 is registered in ClinicalTrials.gov with NICHD Global Network for Women's and Children's Health as lead sponsor.

NCT NCT06855108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06855108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Caffeine for Hypoxic Ischemic Encephalopathy (CHIME Trial)
Lead sponsor
NICHD Global Network for Women's and Children's Health
Phase
Phase 3
Overall status
Recruiting
Start date
April 8, 2026
Completion date
July 31, 2030
Enrollment
830 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxic ischemic encephalopathy (hie)